Skip to Content
 

News: Head and Neck Cancer

Head and neck cancer screening event set for April 12

Thursday, April 4th, 2019

The free annual screening will be Friday, April 12, from 9 a.m. to 3 p.m., at the John S. Odess Clinic for Otolaryngology and Head and Neck Surgery in the Vanderbilt Bill Wilkerson Center at 7209 Medical Center East, South Tower. No appointment is necessary.

Symposium explores prevention of HPV-associated cancers

Friday, March 15th, 2019

Physicians and researchers from across the country came to the Vanderbilt Symposium on HPV Infections and Associated Cancers on March 1 to discuss screening and prevention strategies for the human papillomavirus (HPV).

HPV Symposium Set For March 1

Monday, February 4th, 2019

Vanderbilt University Medical Center will host an educational symposium on human papillomavirus (HPV) and associated cancers on Friday, March 1.

Vanderbilt Biophotonics Center collaboration seeks earlier diagnosis of throat cancer

Saturday, December 1st, 2018

Researchers in the schools of engineering and medicine are exploring the use of Raman spectroscopy for early detection of HPV-related cancers of the throat in order to reduce the need for biopsies and to offer less intensive therapies.

Surgeon helps restore cancer patients’ functionality

Tuesday, November 20th, 2018

Sarah Rohde, MD, specializes in treating cancers in the head, neck and thyroid. A large part of her practice is microvascular free flap reconstruction, or using other parts of the body to reconstruct tissue removed through surgery.

Awareness, education goal of new HPV initiative

Monday, March 12th, 2018

Ronald Alvarez, MD, chair of the Department of Obstetrics and Gynecology, has formed the HPV-Associated Cancer Consortium Vanderbilt (HPVACTIVE) program to raise awareness and provide community-wide education about HPV-associated cancers.

Study to explore cancer survivorship, sexuality

Thursday, November 9th, 2017

Vanderbilt University School of Nursing (VUSN) Assistant Professor Bethany Rhoten, Ph.D., MSN, R.N., has been awarded a $30,000 grant through a Vanderbilt-Ingram Cancer Center-administered American Cancer Society pilot program to investigate the need for a self-report tool to assess sexuality in head and neck cancer patients.

STINGing combination for cancer

Thursday, June 22nd, 2017

Cyclic dinucleotides (CDNs) are intracellular messengers produced in bacteria that can bind to and activate an immune-mediated signaling cascade called STING in mammalian cells. CDNs have shown antitumor activity in melanoma and breast tumors. Reporting this month in the journal Head & Neck, Young J. Kim, M.D., Ph.D., associate professor of Otolaryngology at Vanderbilt University, […]

Glowing receptors help find and track cancerous growth

Friday, May 19th, 2017

Under the microscope, they sparkle like emeralds, these molecules that may hold a key to understanding — and stopping — cancerous growth. The molecules are protein receptors that bind epidermal growth factor (EGF). Overexpression of the EGF receptor has been linked to multiple types of cancer. Drugs that block the receptor have become routine treatment […]

Researchers seek best ways to increase HPV vaccination rates

Friday, May 12th, 2017

Tennessee has one of the lowest human papillomavirus (HPV) vaccination rates in the nation, and investigators at Vanderbilt University Medical Center (VUMC) are hoping to change this by improving the way medical providers present these vaccines to patients and by improving patient and patient family education. “HPV is the most commonly sexually transmitted infection in […]

Next Page »